Lurasidone in adolescents with schizophrenia: Sustained remission and recovery during 2 years of open-label treatment
Autor: | M. Tocco, A. Pikalov, L. Deng, R. Goldman |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | European Psychiatry, Vol 64, Pp S165-S166 (2021) |
Druh dokumentu: | article |
ISSN: | 0924-9338 1778-3585 |
DOI: | 10.1192/j.eurpsy.2021.441 |
Popis: | Introduction Compared with adult onset, early onset schizophrenia is typically characterized by greater illness severity and less favorable prognosis. Objectives To evaluate the proportion of adolescent patients with schizophrenia who achieved sustained remission and recovery during 2 years of treatment with lurasidone. Methods Patients aged 13-17 years with a DSM-IV-TR diagnosis of schizophrenia, and a Positive and Negative Symptom Scale (PANSS) total score ≥70 and |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |